RxDoctor Payments Data

Juliet Vento

Internal Medicine · Miami, FLNPI 1326467887

Payments from drug & device makers

$733,568in general payments, 2019–2025

Across 17 payments — averaging $43,151 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$717K
  • Novartis$15K
  • Novo Nordisk AS$540
  • E.r. Squibb & Sons, L.L.C.$312
  • AbbVie$124
  • Novo Nordisk$122
  • plus $133 from 2 others
$2,374in research payments, 2019–2025

Across 1 payment — averaging $2374.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2K

What the payments were for

  • Consulting fees$54059%
  • Food & beverage$37941%

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly7$717,116
Novartis1$15,221
Novo Nordisk AS1$540
E.r. Squibb & Sons, L.L.C.1$312
AbbVie1$124
Novo Nordisk1$122
Merck3$100
Lilly USA, LLC2$32

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$733,568 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Other internal medicine in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →